Form 4: Nektar Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Howard W Robin, President & CEO and a Director of Nektar Therapeutics, sold 418 shares of common stock on August 18, 2026 for $71.98 per share.
Summary
- Open-market sale: disposed of 418 Common Stock at $71.98 ($30,088) on August 18, 2026; holds 54,627 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $30,088 of stock on the open market.
Insider Transactions
Howard W Robin — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 418 | $72 | $30.1K | 54,627 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (418 shares) |
Keywords
insider transaction, Form 4, NKTR, NEKTAR THERAPEUTICS, bearish, Howard W Robin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.